EPRS1
Bifunctional glutamate/proline--tRNA ligase
Also known as: EARS, EPRS, GLUPRORS, PARS, QARS, QPRS, SYEP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07814
- Gene
- EPRS1
- Ensembl
- ENSG00000136628
- Chromosome
- 1
- Canonical length
- 1512 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol,Mid piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a multifunctional aminoacyl-tRNA synthetase that catalyzes the aminoacylation of glutamic acid and proline tRNA species. Alternative splicing has been observed for this gene, but the full-length nature and biological validity of the variant have not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1512 residues, UniProt reviewed canonical sequence.
>P07814|EPRS1
1 MATLSLTVNS GDPPLGALLA VEHVKDDVSI SVEEGKENIL HVSENVIFTD VNSILRYLAR
61 VATTAGLYGS NLMEHTEIDH WLEFSATKLS SCDSFTSTIN ELNHCLSLRT YLVGNSLSLA
121 DLCVWATLKG NAAWQEQLKQ KKAPVHVKRW FGFLEAQQAF QSVGTKWDVS TTKARVAPEK
181 KQDVGKFVEL PGAEMGKVTV RFPPEASGYL HIGHAKAALL NQHYQVNFKG KLIMRFDDTN
241 PEKEKEDFEK VILEDVAMLH IKPDQFTYTS DHFETIMKYA EKLIQEGKAY VDDTPAEQMK
301 AEREQRIDSK HRKNPIEKNL QMWEEMKKGS QFGQSCCLRA KIDMSSNNGC MRDPTLYRCK
361 IQPHPRTGNK YNVYPTYDFA CPIVDSIEGV THALRTTEYH DRDEQFYWII EALGIRKPYI
421 WEYSRLNLNN TVLSKRKLTW FVNEGLVDGW DDPRFPTVRG VLRRGMTVEG LKQFIAAQGS
481 SRSVVNMEWD KIWAFNKKVI DPVAPRYVAL LKKEVIPVNV PEAQEEMKEV AKHPKNPEVG
541 LKPVWYSPKV FIEGADAETF SEGEMVTFIN WGNLNITKIH KNADGKIISL DAKLNLENKD
601 YKKTTKVTWL AETTHALPIP VICVTYEHLI TKPVLGKDED FKQYVNKNSK HEELMLGDPC
661 LKDLKKGDII QLQRRGFFIC DQPYEPVSPY SCKEAPCVLI YIPDGHTKEM PTSGSKEKTK
721 VEATKNETSA PFKERPTPSL NNNCTTSEDS LVLYNRVAVQ GDVVRELKAK KAPKEDVDAA
781 VKQLLSLKAE YKEKTGQEYK PGNPPAEIGQ NISSNSSASI LESKSLYDEV AAQGEVVRKL
841 KAEKSPKAKI NEAVECLLSL KAQYKEKTGK EYIPGQPPLS QSSDSSPTRN SEPAGLETPE
901 AKVLFDKVAS QGEVVRKLKT EKAPKDQVDI AVQELLQLKA QYKSLIGVEY KPVSATGAED
961 KDKKKKEKEN KSEKQNKPQK QNDGQRKDPS KNQGGGLSSS GAGEGQGPKK QTRLGLEAKK
1021 EENLADWYSQ VITKSEMIEY HDISGCYILR PWAYAIWEAI KDFFDAEIKK LGVENCYFPM
1081 FVSQSALEKE KTHVADFAPE VAWVTRSGKT ELAEPIAIRP TSETVMYPAY AKWVQSHRDL
1141 PIKLNQWCNV VRWEFKHPQP FLRTREFLWQ EGHSAFATME EAAEEVLQIL DLYAQVYEEL
1201 LAIPVVKGRK TEKEKFAGGD YTTTIEAFIS ASGRAIQGGT SHHLGQNFSK MFEIVFEDPK
1261 IPGEKQFAYQ NSWGLTTRTI GVMTMVHGDN MGLVLPPRVA CVQVVIIPCG ITNALSEEDK
1321 EALIAKCNDY RRRLLSVNIR VRADLRDNYS PGWKFNHWEL KGVPIRLEVG PRDMKSCQFV
1381 AVRRDTGEKL TVAENEAETK LQAILEDIQV TLFTRASEDL KTHMVVANTM EDFQKILDSG
1441 KIVQIPFCGE IDCEDWIKKT TARDQDLEPG APSMGAKSLC IPFKPLCELQ PGAKCVCGKN
1501 PAKYYTLFGR SYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPRS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 79 nTPM
- tongue: 52 nTPM
- parathyroid gland: 51 nTPM
- skeletal muscle: 51 nTPM
- pancreas: 46 nTPM
- retina: 41 nTPM
Single-cell type
- salivary acinar cells: 251 nCPM
- plasma cells: 219 nCPM
- erythrocyte progenitors: 214 nCPM
- alveolar cells type 1: 164 nCPM
- pancreatic acinar cells: 157 nCPM
- corticotrophs: 147 nCPM
Immune cell
- MAIT T-cell: 28 nTPM
- intermediate monocyte: 25 nTPM
- myeloid DC: 23 nTPM
- naive CD8 T-cell: 23 nTPM
- NK-cell: 23 nTPM
- non-classical monocyte: 22 nTPM
Brain region
- white matter: 56 nTPM
- cerebellum: 48 nTPM
- pons: 48 nTPM
- spinal cord: 47 nTPM
- hypothalamus: 46 nTPM
- medulla oblongata: 46 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EPRS1.
Disease | AllUniProt
Conditions EPRS1 is implicated in, by any mechanism.
- Leukodystrophy, hypomyelinating, 15 (HLD15) MIM:617951
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 535 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leukodystrophy, hypomyelinating, 15
- Global developmental delay
- Intellectual disability
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- DepMap mean gene effect
- -1.66
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to insulin stimulus
- cellular response to type II interferon
- glutamyl-tRNA aminoacylation
- negative regulation of translation
- prolyl-tRNA aminoacylation
- tRNA aminoacylation for protein translation
- regulation of long-chain fatty acid import into cell
Molecular functions
- ATP binding
- glutamate-tRNA ligase activity
- GTPase binding
- identical protein binding
- proline-tRNA ligase activity
- protein homodimerization activity
- RNA stem-loop binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WHEP-TRS domain
- Glutamyl/glutaminyl-tRNA synthetase
- Aminoacyl-tRNA synthetase, class I, conserved site
- Aminoacyl-tRNA synthetase, class II (G/ P/ S/T)
- Anticodon-binding
- Aminoacyl-tRNA synthetase, class II
- uS15/NS1, RNA-binding domain superfamily
- Large ribosomal subunit protein bL25/Gln-tRNA synthetase, anti-codon-binding domain superfamily
- Rossmann-like alpha/beta/alpha sandwich fold
- Large ribosomal subunit protein bL25/Gln-tRNA synthetase, N-terminal
- Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain
- Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain
- Glutathione S-transferase, C-terminal domain superfamily
- Anticodon-binding domain superfamily
- Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)
- tRNA synthetases class I (E and Q), anti-codon binding domain
- Nuclear-export cofactor Arc1-like, N-terminal domain
- WHEP-TRS domain
- tRNA synthetase class II core domain (G, H, P, S and T)
- tRNA synthetases class I (E and Q), catalytic domain
- Anticodon binding domain
- tRNA synthetases class I (E and Q), anti-codon binding domain
- tRNA synthetases class I (E and Q), anti-codon binding domain
- Nuclear-export cofactor Arc1p
- Proline-tRNA ligase, class IIa, archaeal-type
- Glutamyl-tRNA synthetase, archaeal/eukaryotic cytosolic
- Proline-tRNA ligase, class II, C-terminal
- Prolyl-tRNA synthetase, class II
- Prolyl-tRNA synthetase, catalytic domain
- Prolyl-tRNA synthetase, C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPRS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPRS1 as an antibody target. Whether an autoantibody or antibody against EPRS1 could matter depends on whether native EPRS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPRS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EPRS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...